FRONTEO Co., Ltd. (Headquarters: Minato-ku, Tokyo, President: Masahiro Morimoto, hereinafter referred to as FRONTEO) announced that the fall prediction AI system "Coroban" is a "special depreciation system for equipment that contributes to securing a regional medical care system". We are pleased to inform you that you are eligible.

　Against the background of the problem of long working hours for medical workers, this system promotes work style reform, secures the health of medical workers, and provides safe and high-quality medical care in the community. The purpose of this is to promote the introduction of equipment and software that contribute to shortening the working hours of medical professionals.When a medical institution that makes a blue return purchases the target equipment, etc., in the first year of acquisition, in addition to the ordinary depreciation amount (fixed rate/fixed amount), the special depreciation limit (acquisition 15% of the total amount) can be amortized ahead of schedule.

　Coroban is a system that uses AI to analyze nursing records written in electronic medical records, assess the risk of inpatients falling, and issue alerts for patients who may fall. By implementing fall risk assessment using AI, we will contribute to the work style reform of medical professionals by improving the efficiency of assessment work and reducing the burden.

　Through research, development and provision of systems and applications using natural language analysis AI developed in-house, FRONTEO will contribute to solving problems at medical and nursing care sites, reducing the workload, improving the quality of medical care and QOL of patients. .

　The single transaction will have a minor impact on business results for the current fiscal year.

■ About Coroban　URL:https://lifescience.fronteo.com/products/coroban/
Coroban is a fall prediction AI system developed by FRONTEO in collaboration with Eisai Inc. FRONTEO's natural language analysis AI "Concept Encoder (trademark: concept encoder, reading: concept encoder)" reads electronic medical records and evaluates the risk of falling from the patient's condition and nursing records.It is possible to make predictions with the same accuracy as the conventional fall / fall risk assessment sheet without increasing the burden on medical staff.Recommended by the Japan Fall Prevention Society.Patent registration number: Patent No. 6652986
* This system is not a medical device.This system predicts the risk of falls and is not intended for the judgment of doctors and nurses.

■ About FRONTEO　URL:https://www.fronteo.com/
FRONTEO uses in-house developed AI engines "KIBIT", "Concept Encoder" and "Looca Cross" that specialize in natural language processing. We are a data analysis company that extracts meaningful and important information from vast amounts of text data to support corporate businesses. Since its founding in August 2003, it has been operating globally in Japan, the United States, South Korea, and Taiwan, with a focus on legal tech businesses such as "e-discovery (electronic discovery)" and "digital forensic investigation" that support international corporate litigation. has been developed.Based on the AI ​​technology cultivated in this business, since 8 we have expanded our business fields to life science, business intelligence, and economic security. We contribute to solving various problems of companies, such as drug discovery support, dementia diagnosis support, and financial/personnel/sales support. June 2014, 2007 Listed on Tokyo Stock Exchange Mothers (currently Tokyo Stock Exchange Growth). In January 6, we acquired the first-class medical device manufacturing and sales license (license number: 26B2021X1), and in September of the same year, we submitted a controlled medical device sales business (report number: 13 Minato Misei device No. 1).Capital 10350 thousand yen (as of March 9, 3).

* FRONTEO, KIBIT, conceptencoder, and Looca Cross are registered trademarks of FRONTEO in Japan.
* Coroban is a registered trademark of Eisai Co., Ltd. and FRONTEO.